First Time Loading...

Guardant Health Inc
NASDAQ:GH

Watchlist Manager
Guardant Health Inc Logo
Guardant Health Inc
NASDAQ:GH
Watchlist
Price: 18.79 USD -0.16%
Updated: May 8, 2024
Section:
 

Relative Value

The Relative Value of one GH stock under the Base Case scenario is 22.86 USD. Compared to the current market price of 18.79 USD, Guardant Health Inc is Undervalued by 18%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

GH Relative Value
Base Case
22.86 USD
Undervaluation 18%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

4.1
P/S
P/S
Price to Sales
4.1
vs History
96
vs Industry
32
Median 3Y
10.9
Median 5Y
28.3
Industry
2.4
Forward
3.3
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-8.8
Median 5Y
-26.7
Industry
23.4
Forward
-5.8
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-17.2
Median 5Y
-57.1
Industry
15.5
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-8.5
Median 5Y
-12.7
Industry
23.2
More Details
14.4
P/B
P/B
Price to Book Value
14.4
vs History
33
vs Industry
4
Median 3Y
15.3
Median 5Y
13.6
Industry
2.3
More Details
4
EV/S
EV/S
Enterprise Value to Sales
4
vs History
96
vs Industry
30
Median 3Y
11.6
Median 5Y
27.4
Industry
2.5
Forward
3.3
More Details
6.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
6.7
vs History
96
vs Industry
35
Median 3Y
17.2
Median 5Y
40.7
Industry
5.3
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-11.3
Median 5Y
-27.6
Industry
12.6
Forward
-6.7
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-10.6
Median 5Y
-26.2
Industry
17.2
Forward
-5.4
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
Median 3Y
-17.8
Median 5Y
-55.3
Industry
15.3
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-13.3
Median 5Y
-42.5
Industry
19.8
More Details
4
EV/IC
EV/IC
Enterprise Value to IC
4
vs History
95
vs Industry
22
Median 3Y
6.2
Median 5Y
13.2
Industry
2
More Details

Multiples Across Competitors

GH Competitors Multiples
Guardant Health Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Guardant Health Inc
NASDAQ:GH
2.3B USD 4.1 -4.8 -4.3 -4
US
Cigna Corp
NYSE:CI
98.5B USD 0.5 27.2 9.8 13
US
Cigna Group
XMUN:CGN
91.3B EUR 0.5 27.1 9.8 12.9
US
CVS Health Corp
NYSE:CVS
69B USD 0.2 9.4 8.6 8.6
DE
Fresenius SE & Co KGaA
XETRA:FRE
16B EUR 0.7 -27 10.2 22.8
US
Laboratory Corporation of America Holdings
NYSE:LH
16.9B USD 1.4 39.1 11.9 17.9
US
Quest Diagnostics Inc
NYSE:DGX
15.2B USD 1.6 18 10.8 14.6
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.3B EUR 0.6 22.7 6.8 16.1
US
DaVita Inc
NYSE:DVA
11.9B USD 1 14.6 8.3 11.8
DE
Fresenius Medical Care AG
XMUN:FME
11B EUR 0.6 22 6.7 15.9
US
Oak Street Health Inc
NYSE:OSH
9.5B USD 4.4 -18.6 -23.3 -21.5

See Also

Summary
GH intrinsic value, competitors valuation, and company profile.
DCF Valuation
GH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GH stock valuation using valuation multiples.
Wall Street Estimates
GH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 135,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.